CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 22 enrolled
Drug / intervention
Epinephrinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04065451
NCT04065451Phase 4Completed
CompareCT.gov

Effect of Epinephrine on Immediate Post-polypectomy Pain in Colorectal Lesions Larger Than 20 mm

Indiana University·interventional·Posted Aug 22, 2019·Updated Sep 30, 2022

In Brief

A Phase 4 clinical trial evaluating Epinephrine for Colonic Polyp. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Epinephrine is widely used in endoscopic mucosal resection of large polyps to prevent post-polypectomy bleeding. No previous studies looked at increase in immediate post-polypectomy pain with the use of epinephrine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonic Polyp
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedAug 22, 2019
Enrollment StartJan 6, 2020
Primary CompletionAug 17, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.9 years ago

Interventions

Epinephrinedrug

Epinephrine in the submucosal injection fluid